These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29962378)

  • 1. GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells.
    Takahashi H; Nomiyama T; Terawaki Y; Kawanami T; Hamaguchi Y; Tanaka T; Tanabe M; Bruemmer D; Yanase T
    J Atheroscler Thromb; 2019 Feb; 26(2):183-197. PubMed ID: 29962378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional regulation of S phase kinase-associated protein 2 by NR4A orphan nuclear receptor NOR1 in vascular smooth muscle cells.
    Gizard F; Zhao Y; Findeisen HM; Qing H; Cohn D; Heywood EB; Jones KL; Nomiyama T; Bruemmer D
    J Biol Chem; 2011 Oct; 286(41):35485-35493. PubMed ID: 21868379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation.
    Nomiyama T; Nakamachi T; Gizard F; Heywood EB; Jones KL; Ohkura N; Kawamori R; Conneely OM; Bruemmer D
    J Biol Chem; 2006 Nov; 281(44):33467-76. PubMed ID: 16945922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1.
    Medunjanin S; Daniel JM; Weinert S; Dutzmann J; Burgbacher F; Brecht S; Bruemmer D; Kähne T; Naumann M; Sedding DG; Zuschratter W; Braun-Dullaeus RC
    Cardiovasc Res; 2015 Jun; 106(3):488-97. PubMed ID: 25852083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of the NR4A neuron-derived orphan receptor-1 attenuates neointima formation after vascular injury.
    Nomiyama T; Zhao Y; Gizard F; Findeisen HM; Heywood EB; Jones KL; Conneely OM; Bruemmer D
    Circulation; 2009 Feb; 119(4):577-86. PubMed ID: 19153266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1.
    Li P; Liu Y; Yi B; Wang G; You X; Zhao X; Summer R; Qin Y; Sun J
    Cardiovasc Res; 2013 Jul; 99(1):185-93. PubMed ID: 23554459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury.
    Hirata Y; Kurobe H; Nishio C; Tanaka K; Fukuda D; Uematsu E; Nishimoto S; Soeki T; Harada N; Sakaue H; Kitagawa T; Shimabukuro M; Nakaya Y; Sata M
    Eur J Pharmacol; 2013 Jan; 699(1-3):106-11. PubMed ID: 23220706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.
    Terawaki Y; Nomiyama T; Kawanami T; Hamaguchi Y; Takahashi H; Tanaka T; Murase K; Nagaishi R; Tanabe M; Yanase T
    Cardiovasc Diabetol; 2014 Nov; 13():154. PubMed ID: 25407968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-derived orphan receptor 1 promoted human pulmonary artery smooth muscle cells proliferation.
    Wang CG; Lei W; Li C; Zeng DX; Huang JA
    Exp Lung Res; 2015 May; 41(4):208-15. PubMed ID: 25844690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of neuron-derived orphan receptor-1 (NOR-1) exacerbates neointimal hyperplasia after vascular injury.
    Rodríguez-Calvo R; Guadall A; Calvayrac O; Navarro MA; Alonso J; Ferrán B; de Diego A; Muniesa P; Osada J; Rodríguez C; Martínez-González J
    Hum Mol Genet; 2013 May; 22(10):1949-59. PubMed ID: 23390133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats.
    Lim S; Lee GY; Park HS; Lee DH; Tae Jung O; Kyoung Min K; Kim YB; Jun HS; Hak Chul J; Park KS
    Cardiovasc Res; 2017 Feb; 113(2):183-194. PubMed ID: 27702762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6.
    Jansen F; Stumpf T; Proebsting S; Franklin BS; Wenzel D; Pfeifer P; Flender A; Schmitz T; Yang X; Fleischmann BK; Nickenig G; Werner N
    J Mol Cell Cardiol; 2017 Mar; 104():43-52. PubMed ID: 28143713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular smooth muscle-MAPK14 is required for neointimal hyperplasia by suppressing VSMC differentiation and inducing proliferation and inflammation.
    Wu W; Zhang W; Choi M; Zhao J; Gao P; Xue M; Singer HA; Jourd'heuil D; Long X
    Redox Biol; 2019 Apr; 22():101137. PubMed ID: 30771750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroartemisinin alleviates AngII-induced vascular smooth muscle cell proliferation and inflammatory response by blocking the FTO/NR4A3 axis.
    Huo YB; Gao X; Peng Q; Nie Q; Bi W
    Inflamm Res; 2022 Feb; 71(2):243-253. PubMed ID: 35059772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose differentiation‑related protein knockdown inhibits vascular smooth muscle cell proliferation and migration and attenuates neointima formation.
    Zhao H; Han T; Hong X; Sun D
    Mol Med Rep; 2017 Sep; 16(3):3079-3086. PubMed ID: 28713961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation.
    Martínez-González J; Rius J; Castelló A; Cases-Langhoff C; Badimon L
    Circ Res; 2003 Jan; 92(1):96-103. PubMed ID: 12522126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
    Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
    Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T; Uchida K; Akimoto K; Tomotsune T; Yanagi K; Iijima T; Suzuki K; Kasai K; Aso Y
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of neuron-derived orphan receptor 1 with pulmonary vascular remodeling in COPD patients.
    Wang CG; Li C; Lei W; Jiang JH; Huang JA; Zeng DX
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1177-1186. PubMed ID: 29695901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolol attenuates neointima formation by inducing cell cycle arrest via inhibition of ERK1/2 and NF-kappaB activation in vascular smooth muscle cells.
    Karki R; Ho OM; Kim DW
    Biochim Biophys Acta; 2013 Mar; 1830(3):2619-28. PubMed ID: 23274740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.